 |
32 Diseases |  |
9 Trials |
|
9 Trials |  |
795 News |  |
| «12345678910111213 |
- ||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
New P1 trial: A Study of Tralokinumab When Delivered Subcutaneously at Different Flow Rates to Healthy Volunteers (clinicaltrials.gov) - Mar 10, 2014
P1, N=60, Recruiting, Sponsor: MedImmune LLC
- | Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Enrollment change: D2212C00002 J-Phase II Study (clinicaltrials.gov) - Feb 9, 2014
P2, N=30, Recruiting, Sponsor: AstraZeneca
N=20 --> 30
- | Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Enrollment open: D2212C00002 J-Phase II Study (clinicaltrials.gov) - Feb 9, 2014
P2, N=30, Recruiting, Sponsor: AstraZeneca
N=20 --> 30 Not yet recruiting --> Recruiting
- | Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
New P2 trial: D2212C00002 J-Phase II Study (clinicaltrials.gov) - Jan 13, 2014
P2, N=30, Recruiting, Sponsor: AstraZeneca
- |||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Trial completion: Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis (clinicaltrials.gov) - Jul 8, 2013
P2a, N=111, Completed, Sponsor: AstraZeneca
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Trial completion: A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma (clinicaltrials.gov) - May 21, 2013
P1, N=22, Completed, Sponsor: MedImmune LLC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Enrollment open: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis (clinicaltrials.gov) - Oct 10, 2012
P2, N=302, Recruiting, Sponsor: MedImmune LLC
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
New P2 trial: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis (clinicaltrials.gov) - Jun 25, 2012
P2, N=302, Recruiting, Sponsor: MedImmune LLC
- | Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
New P1 trial: A Phase 1, Open-label Study to Investigate the Pharmacokinetics of Tralokinumab (CAT-354) in Adolescents With Asthma (clinicaltrials.gov) - May 3, 2012
P1, N=22, Completed, Sponsor: MedImmune LLC
- ||||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
New P2a trial: Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis (clinicaltrials.gov) - Nov 29, 2011
P2a, N=111, Completed, Sponsor: AstraZeneca